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Quality of life (QoL) is recognized as an essential end point in the disease management of
chronic conditions such as HIV with calls to include good QoL as a ‘fourth 90’ in the 90-90-
90 testing and treatment targets introduced by World Health Organization in 2016. Cognitive
impairments impact a broad spectrum of experiences and are a common issue effecting
people living with HIV (PLWH). Despite this, few studies have examined QoL in PLWH who
also have a cognitive disorder. This study aimed to synthesize and describe what is known
about QoL in those living with HIV-associated neurocognitive disorders (HAND). A scoping
review of peer-reviewed literature was conducted to identify how QoL has been investigated
and measured in PLWH with HAND, and how PLWH with HAND report and describe their
QoL. We searched PsychInfo, Medline, Scopus, and Web of Science along with hand-
searching reference lists from relevant studies found. Included studies were those published
in English after 1st January 2003 which included PLWH with cognitive impairment not due to
other pre-existing conditions. Fifteen articles met criteria for inclusion. Two studies mea-
sured QoL as a primary aim, with others including QoL assessment as part of a broader bat-
tery of outcomes. The MOS-HIV and SF-36 were the most commonly used measures of
overall QoL, with findings generally suggestive of poorer overall QoL in PLWH with HAND,
compared to PLWH without cognitive impairment. Studies which examined dimensions of
QoL focused exclusively on functionality, level of independence, and psychological QoL
domains. There is a considerable dearth of research examining QoL in PLWH with HAND.
The initiatives which advocate for healthy aging and improved QoL in PLWH must be
extended to include and understand the experiences those also living with cognitive
impairment. Research is needed to understand the broad experiential impacts of living with
these two complex, chronic conditions, to ensure interventions are meaningful to patients
and potential benefits are not missed.
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Introduction
Worldwide approximately 38 million people live with human immunodeficiency virus (HIV)
with 1.7 million new cases seen each year [1]. While life expectancy has greatly increased due
to effective combination antiretroviral therapy (cART), cognitive disorders remain a signifi-
cant issue for people living with HIV (PLWH) and those who care for them. HIV-associated
dementia, which was seen in up to 50% of PLWH in the pre-cART era, is now rare, however, a
mild to moderate profile of cognitive impairment impacting quality of life (QoL), medication
adherence, and employment is widely reported [2–5].
HIV-associated Neurocognitive Disorder (HAND) is the term coined to refer to clinically
significant declines in multiple domains of neuropsychological functioning that are not exclu-
sively attributable to factors other than HIV infection. For research purposes, the gold-stan-
dard Frascati Criteria [6] is commonly used to identify HAND across three thresholds of
impairment (asymptomatic Neurocognitive Impairment (ANI); mild neurocognitive Disorder
(MND); and HIV-associated Dementia (HAD)). Frascati Criteria–based HAND involves test-
ing across broad cognitive domains, with HAND identified when two or more domains are
one or more standard deviations below normative scores and for MND and HAD when daily
functioning is impacted. Notably, for a clinical diagnosis of HAND (based on Diagnostic and
Statistical Manual of Mental Disorders (5th ed; DSM-5) [7], impairment must be reported both
objectively (e.g., decline in standard neuropsychological testing) and subjectively (e.g., com-
plaints), whereas evidence of subjective impairment is not required for Frascati Criteria-based
HAND identification. Additionally, there must be no evidence of a pre-existing cause for
impairment. Prevalence rates vary depending on definitions of cognitive impairment used,
with studies reporting cognitive impairment in as many as 52% of PLWH [8], which may or
may not be related to HIV. Those with more stringent definitions estimate that between 14–
28% of PLWH experience these issues [9]. Prevalence of cognitive impairment, however, is
expected to rise as the HIV-population continues to age, whereby the impacts of aging and
associated morbidities compound the cognitive vulnerabilities already seen in PLWH.
With 73% of PLWH in Europe estimated to be over 50 years of age by 2030, an emerging
consensus that we need to measure broad patient-rated outcomes such as quality of life (QoL)
along with discrete areas of function like cognition and mental health, has emerged. Examina-
tion of QoL allows healthcare providers a more thorough understanding of the factors impact-
ing PLWH and facilitates the provision of optimum person-centred care [10]. QoL is
commonly conceived as dynamic, subjective and multidimensional, with dimensions often
including physical, psychological, social, and spiritual factors [11] relating to ‘an individuals’
perception of their position in life in the context of the culture and value systems in which they
live and in relation to their goals, expectations, standards and concerns’ [12]. Assessment of
QoL has been widely embraced in generic HIV clinical care, with the World Health Organiza-
tion (WHO) endorsing QoL as an important and prominent patient-reported outcome in clin-
ical care and intervention efficacy, along with HIV advocacy groups calling for its inclusion as
an additional 90 in the 90-90-90 testing and treatment target introduced by the World Health
Organization in 2016 [13]. However, PLWH with HAND have been recognised as an under-
served population in healthcare [14]. To date much of the research into HAND has focused on
etiology, diagnosis and treatment (e.g. improved management of clinical variables contribut-
ing to impairments) with little consideration for the experiential consequences of having two
chronic, stigmatizing, and potentially debilitating conditions.
There is value in examining the literature to identify what is currently known about the
relation between QoL in PLWH with HAND to provide a better overall picture of the experi-
ences of these individuals. Mapping what is known about the QoL of those living with HIV
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with HAND, this review will identify the gaps in knowledge allowing the formulation of new
research requirements. To the best of our knowledge, a synthesis or summary of the evidence
pertaining to QoL in PLWH with HAND has not been previously conducted. Therefore, a
mapping or scoping (i.e. summarising the range of evidence to report breadth and depth) of
the research conducted will contribute to a better understanding of the situation. Here we
describe the extent, range, and nature of the body of knowledge on QoL in PLWH with
HAND for the purpose of providing a systematic, synthesised summary of the evidence. Exam-
ining the research on QoL in those PLWH with HAND will help provide a basis for mitigating
negative outcomes, such as health risk and burdens for both those with HAND and their fami-
lies/carers, along with interventions to advance wellbeing and QoL. With this in mind the
research questions are:
1. How has QoL been investigated and measured with regard to PLWH with HAND?,
2. How do PLWH with HAND report and describe their QoL?
Methods
A scoping review was selected based on preliminary searches showing that studies examining
QoL in PLWH with HAND were lacking, with the majority of studies found either not exam-
ining QoL (or any dimension associated with QoL) or not look at those PLWH with HAND.
Munn et al. [15] states the utility of scoping reviews, as opposed to systematic reviews, when
examining limited, disparate, or emerging evidence, and when broad as opposed to specific
questions are posed. These indications allow for questions regarding types of available evi-
dence, how the research has been conducted, key factors or characteristics of a topic, and the
identification of gaps in knowledge, and as such, was considered most appropriate for this
research topic. A scoping review was conducted with the assistance of an experienced librarian
(A.F) using systematic search methods. Our objectives were to document the available evi-
dence describing the methods used to measure and capture QoL experiences, along with
describing how PLWH with HAND report their QoL. Our choice of review method was fur-
ther informed following initial searches in Google Scholar and the database Scopus. This pre-
liminary search showed that studies examining QoL in PLWH with HAND were lacking, with
the majority of studies found either did not examine QoL (or any dimension associated with
QoL) or did not look at those PLWH with HAND. The framework employed to structure and
inform this review was developed by Arksey and O’Malley [16], with further guidance from
later publications, including the Preferred Reporting Items for Systematic Reviews and Meta-
Analyses Extension for Scoping Reviews (PRISMA-ScR) (S1 Table) [17, 18]. It consists of six
stages: identifying the research question; searching for relevant studies; deciding on studies for
inclusion; charting the data; collating, summarizing, and reporting study findings; and con-
sulting stakeholders [16]. Study limitations resulted in no stakeholder consultation for this
review, however, all other steps were followed. So as to allow a broad map of the literature
there was an agreement to include articles which describe a multi-dimensional evaluation of
QoL and to extract and report associations related to QoL that were statistically significant (i.e.
95% Confidence Level).
Identifying relevant studies
We conducted a broad search of peer-reviewed literature. Searches were conducted of four
electronic databases: Scopus, Web of Science, Medline and PsychInfo, to identify peer-
reviewed literature, with the last searches performed on 25th September 2020. Date limit was
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set at studies published from 1st January 2003 onwards, due to this being the time with which
access to cART became more widely available. Searches involved analysis of text words con-
tained in the title and abstract, and of the index terms used to describe the article. A second
search using all identified keywords and index terms was then conducted across all databases.
Our search strategy was designed to be broad and sensitive enough to ensure we capture all rel-
evant studies (Table 1) and included specifications of the context (PLWH), participant
(HAND) and concept (quality of life). The context terms consisted of HIV, AIDS, HIV/AIDS,
Human immunodeficiency virus. The participants term included HAND, HIV-associated neu-
rocognitive impairment, cognitive impairment, neurocognitive impairment. The term concept
consisted of quality of life, health-related quality of life, well-being, life satisfaction and func-
tioning. In addition, reference lists of relevant studies and reviews found were also hand-
searched to ensure there was comprehensive coverage of the research topic.
Table 1 presents the search strategy that was used for Scopus, which was adapted in minor
ways for other databases.
Study selection
Inclusion and exclusion criteria. Quantitative and qualitative peer-reviewed, original
research papers were included, reviews, commentaries and editorials were excluded. Interven-
tional studies were excluded, as it is possible that the mechanism with which the intervention
impact QoL complicates the interpretation of the outcome and will affect the clarity of infer-
ences drawn. Given the aim included summarising knowledge status, grey literature was not
included as the findings had not been published in peer-reviewed journals. Only articles pre-
sented in English were considered for inclusion.
Context. Studies must state that participants either were on Highly active antiretroviral
therapy (HAART) or cART or had access to HAART or cART, to this end only studies dated
1st January 2003 onwards were considered for review, as this is when the availability of
HAART/cART became widespread. Prior to the advent of effective ARVs, the impacts HIV/
AIDS and antiretroviral therapies had on QoL was hugely significant [19], this review seeks to
consolidate QoL for those with HAND in the era of effective treatment (i.e. HAART or cART).
Participants. Studies had to include populations over 18 years. Studies considered for
inclusion must have demonstrated that the cognitive impairment seen in the sample are pri-
marily due to HIV-associated factors (i.e. HAND) e.g. the primary reason for impairments is
not a mental illness, Alzheimer’s dementia, or cardiovascular disease. For this to be evident,
Table 1. Search strategy terms.
Search terms
Context Concept
#1 HIV (263,618) #10 “quality of life” (425,651)
#2 AIDS (155,378) #11 QoL (40,042)
#3 HIV/AIDS (76,220) #12 “health-related quality of life” (44,122)
#4 “Human immunodeficiency�” (242,879) #13 H?QoL (16,556)
#5 (#1 or #2 or #3 or #4) (377,902) #14 “well-being” (135,714)
Participants #15 “life satisfaction” (16,941)
#6 HAND (830,550) #16 function� (6,240,621)
#7 “HIV-associated neuro�” (1,664) #17 (#10 or #11 or #12 or #13 or #14 or #15 or #16) (147,602)
#8 “Cognitive impairment” (71,264)
#9 Neurocognitive� (22,041) Combined search:
#10 (#6 or #7 or #8 or #9) (918,754) #5 and #10 and #17 (217)
https://doi.org/10.1371/journal.pone.0251944.t001
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studies needed to demonstrate that the population selected for study has a diagnosis of
HAND, which is based on the current ‘gold standard’ Frascati criteria [6]. Therefore, studies
must have detailed evidence that the population sampled had i) acquired impairment in cogni-
tive functioning, involving at least two domains, documented by performance of at least 1
standard deviation below the mean for age-education-appropriate norms on standardized
neuropsychological tests, and ii) impairment decidedly due to primarily HIV-related factors,
with no evidence of another pre-existing cause likely to be primarily responsible for the cogni-
tive impairments seen.
Concept. The key concept is QoL, including its multidimensional components. With this
in mind studies examining the components of QoL will be considered for review. For the pur-
pose of this review components included are physical health, psychological state, functionality,
level of independence, social relations, environment, and spirituality/religion/personal beliefs
[12]. While, functionality is not considered to comprise the QoL concept by the WHO [12],
other authors argue it be a relevant and informative proxy or dimension of QoL [20, 21] (19),
which has been validated in HIV populations [22]. With this in mind, studies examining func-
tionality (e.g. activities of daily living; ADL) will be considered for review.
Search results. The search strategy in the four different databases resulted in a total of
1005 articles being identified. These records were exported into EndNoteX8. Two articles were
identified through hand-searching relevant articles reference list. The removal of duplicate rec-
ords resulted in 543 records left for title and abstracts screening. The screening was performed
by one author (KA), under the close guidance of the second author (JV) who was consulted
where inclusion was unclear. KA and JV finally agreed to 92 records as relevant studies for
full-text screening. KA and JV then independently screened full-text studies to assess eligibility
for inclusion in the review. KA screened the reference lists of the included studies. Of the 92
records considered for inclusion, there was disagreement on 2 (2.2%), in which cases discus-
sion meetings were held until an agreement was reached. Of the 92 screened full-text articles,
78 were excluded. The majority of articles were not considered to be examining HAND i.e.
cognitive impairment was not distinguished from other potential causes, or participants were
not assessed using a neuropsychological test battery and impairments were subjective. A num-
ber of studies did not examine QoL in any depth (i.e. a single-item QoL question was
employed and no other QoL domains were examined or had ineligible study populations) or it
could not be confidently concluded participants had access to effective ARV therapy. A total of
15 articles were included in the review (Fig 1).
Charting the data
Information relating to QoL in PLWH with HAND were examined by two authors (KA and
JV) who utilized processes from qualitative content analysis [23]. This required three phases of
analysis: preparation, organization, and reporting, which was conducted using a structured
data tool. KA extracted the study characteristics, which was then reviewed by JV, and any con-
flicts were discussed until resolution was reached. Given this was a scoping review, study qual-
ity (e.g. possible bias, sample sizes) was not evaluated [16]. Tables 2 and 3 detail the
systematization and categorization of study characteristics and results included in the review,
based on the research questions.
Collating, summarising, and reporting the results
Study characteristics and main findings of the 15 studies included in this review are presented
in Table 2. Studies are ordered by year of publication, with those published in the same year
grouped in order of author surname.
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Results
The results of this review are reported in line with the review questions. Of the 1005 peer-
reviewed abstracts, 75 were advanced for full-text review which yielded 15 articles that met
inclusion criteria (Fig 1). The results section first describes the study characteristics (Table 2)
and details how QoL has been assessed in this population, we then describe how PLWH with
HAND report their QoL.
Eight studies were conducted in the United States [24, 31, 32, 35, 38, 40, 42, 47], three stud-
ies were conducted in Canada [45, 49, 51], two were conducted in Italy [27, 30], one study con-
ducted in Brazil [50], and one in the United Kingdom [43]. The primary aim of the majority of
studies was to examine functional deficits associated with HAND, which was assessed via ‘real-
world’ functional assessments [24, 31, 32, 47] or through patient-reported outcome measures
(PROMs) of functioning [24, 31, 32, 35, 40, 47], with broad QoL assessment or the assessment
of a second QoL component an additional secondary aim in some studies [24, 32, 38]. Four
studies examined the impact of HAND on health-related QoL (HRQoL) [27, 30, 38, 45], two
studies assessed psychological state in those with HAND [50, 51], one study examined the
impact of positive health behaviours on HAND [42], one study examined associations between
different PROMs and HAND [43], and one study explored how HAND impacted well-being
Fig 1. PRISMA flowchart.
https://doi.org/10.1371/journal.pone.0251944.g001
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(Continued)
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broadly [49]. In six of the studies patients were recruited from HIV outpatient clinics [32, 35,
38, 45, 50, 51], five studies recruited patients from ongoing research cohorts [24, 31, 40, 43,
47], two studies recruited from community settings [42, 49], and two studies recruited from a
neurology clinic [27, 30]. Fourteen studies employed quantitative methodologies: seven studies
were case-control studies [35, 38, 40, 42, 43, 47, 51] and seven has a cross-sectional design [27,
30–32, 45, 50]. One qualitative study was included, which employed interpretative qualitative
methods [49].
Population
One study was conducted with PLWH with HAND exclusively [49], this is likely due to the
qualitative methodology used. Seven studies [24, 27, 30, 42, 45, 50] included a single compara-
tor group; PLWH without HAND, five studies [31, 35, 38, 40, 43, 47] included two comparator
groups; PLWH without HAND and HIV-negative controls, and one study [32] examined dif-
ferences across HAND severity (e.g. No cognitive impairment, ANI, MND, and HAD), and
one study [38] examined differences between older and younger PLWH and HIV negative
controls, with HAND status being a factor examined among other variables.
Participants totaled 2286, of these 1052 had diagnosed HAND. Of those with HAND 595
participants were male and 192 were female. Gender distinctions for those with HAND were
not available for 4 studies [24, 38, 42, 43], this was due to the primary aim not being outcome
across HAND categorization (HAND vs. no HAND) [24, 38, 42] or multiple methods of
HAND diagnosis being examined with gender not distinguished between methods [43]. None
of the studies report whether neuropsychological testing considered gender distinctions for
normative scores or whether it was considered in diagnosing HAND, however this would nor-
mally only be examined in association analyses which seek to examine gender distinctions in
HAND. The average age of HAND participants was approximately 44 years. An exact calcula-
tion based on all studies included was not possible as mean age was not reported for those with
HAND [42, 43, 45] or median age was given [43]. The majority of studies did not provide eth-
nicity data for those with HAND [24, 27, 30, 38, 42, 43, 45, 50, 51]. In studies which did Cauca-
sian/white participants comprised 45.8%, Black/African/African-American/Caribbean
participants representing 41.2%, and Hispanic participants comprising 8.2% of the sample. All
but one study [49] gave information pertaining to the ARV status of participants; four studies
stated that all participants were on stable cART [32, 38] or HAART [27, 30], and across the
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this review [49], despite not providing ARV status information (likely due to its qualitative
methodology and that it was not deemed relevant for the objectives of the research) however,
contact was made with the study authors who confirmed all participants had access to cART.
QoL measures
Measures used to assess QoL are listed in Table 3. A relatively small number of multidimen-
sional QoL instruments were used. Only four studies used an instrument with the capacity to
Table 3. QoL measures and dimensions.
Instrument QoL domains examined Study inclusion
Medical Outcomes Survey–MOS-HIV (35-item)
[52]
Physical functioning [27, 30]
Role functioning [32]—Role functioning items and the








SF-36 (6-items) [39] Physical functioning [38, 43]






EVGGFP (Single-item HRQoL measure) [46] HRQoL [45, 51]





Patient’s Own Assessment of Functioning
Inventory PAOFI (41-items) [26]
Functioning (domains examined: memory, language and




Karnofsky Performance Scale Index (11-point
rating scale ranging from normal functioning to
dead) [29]
Physical functioning [27, 30, 32, 38, 42, 47]
Level of independence
Lawson & Brody Instrumental Activities of Daily
Living–Modified (8-items) [31]
Physical functioning [31, 35, 38, 40, 43, 47]
Level of independence
Health status
(Functional ability across 8 common daily, ‘complex’ tasks (Telephone
use, Shopping, Food preparation, Housekeeping, Laundry,
Transportation, Medication management and Financial management)
ALF Questionnaire (9-items) [32] Physical functioning [32]
Mental functioning
Social functioning
PHQ-9 (9-item) [44] Mental health [43, 45, 51]
Beck Depression Inventory BDI-II (21-Item) [53] Mental health [32, 40, 50]
Profile of Mood States POMS (65-items) [37] Mental wellbeing [35]
https://doi.org/10.1371/journal.pone.0251944.t003
PLOS ONE Quality of life in people with HAND
PLOS ONE | https://doi.org/10.1371/journal.pone.0251944 May 19, 2021 13 / 23
examine QoL broadly [27, 30, 38, 43]. The MOS-HIV [52], modified and validated for use in
PLWH, was utilized by two studies [27, 30]; it measures ten dimensions of QoL and allows the
user to calculate a physical (PHS) and mental health summary score (MHS) and an overall
QoL score. Likewise, the newer Short-Form Survey 36 (SF-36) [39], was employed by two
studies [27, 30, 38, 43], and can be described both as a generic health instrument and a health-
related QoL tool. It covers eight domains, and allows the administer to calculate a PHS, MHS,
and overall QoL score. Two studies; [45, 51] used the EVGGFP [46], a single-item measure of
HRQoL, which asks patients to rate their HRQoL today, and yields moderate validity for
assessing HRQoL in PLWH [46].
A number of studies, in addition to the broader QoL instruments aforementioned [30, 43,
47], used PROMs to examine manifest functioning. Lawson & Brody Instrumental Activities
of Daily Living Scale—modified [31, 54] was used by six studies [31, 35, 38, 40, 43, 47] and the
Patient’s Own Assessment of Functioning Inventory (POAFI) [26] was used by three studies
[24, 40, 47]. These measures broadly assess day-to-day functional abilities (e.g. medication
management, cooking) and patients’ perceptions of a wide array of functional abilities (e.g.
memory, language and communication). Four studies [30, 38, 42, 47] included the Karnofsky
Performance Scale (KPS) [29], which provides a broad indication of functional ability and
insight into overall health status. One study [24] used the Katz Adjustment Scale (KAS-P) [25]
which examines functional ability, along with evaluating health perceptions and health satis-
faction. A purpose-build assessment measure of ‘Active Lifestyle Factors’ was developed by
one study [42] to examine physical health, social activity and mental activity (via proxies of
physical exercise, social connectiveness and employment).
Measures of psychological state were employed by eight studies, all of which focused on
depression and anxiety symptomatology using the Patient’s Health Questionnaire (PHQ-9)
[43–45, 51], Beck Depression Inventory II (BDI- II) [31, 32, 50], and the Patient’s Own Mood
State (POMS) [35].
How do PLWH with HAND report their QoL?
QoL overall. Studies found overall QoL was reduced in those with HAND compared to
controls [27, 30, 38, 43, 51], however, this was significant in only two studies [27, 30]. Global
QoL expectation was significantly lower in those with HAND compared to those without a
cognitive impairment [24]. Experientially PLWH with HAND described day-to-day fluctua-
tions, and ‘good days and bad days’ in moods and abilities, which yielded prominent down-
stream effects on their perceptions of QoL.
Physical health. PLWH with HAND reported summative worse physical health summary
QoL scores [27, 30, 43]. In addition, pain and energy QoL sub-domains were found to be sig-
nificantly worse in PLWH with HAND [27, 30]. These findings were corroborated by qualita-
tive reported of poor sleep mediating cognitive disfunction, missed or forgotten meals,
problematic medication adherence, and missed medication appointments which likely impact
physical health and wellbeing [49].
Psychological. Overall studies which examined psychological QoL [27, 30, 32, 35, 40, 43,
45, 50, 51] indicate that PLWH with HAND experience lower rates of psychological QoL.
Three studies found those with HAND reported lower MHS and poorer mental health QoL
[27, 30, 43]. Studies which additionally employed a mental health measure [32, 35, 40, 43, 45,
50, 51] found higher instances of depressive and anxious symptoms in those with HAND com-
pared to controls [35, 40, 43, 50] and a positive association between depressive symptomology
and severity of cognitive impairment [32]. Qualitatively, participants reported the broad
impacts of HAND on their psychological QoL, including its impact on self-esteem, self-
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concept, identity, mood (including stress, worries, depressive/anxious symptoms), anxieties
regarding the future, and self and felt stigma.
Level of independence. Studies reported negative relationships between level of indepen-
dence and presence of HAND on QoL [38]. HAND impacts complex or instrumental ADLs
such as cooking, shopping, medication and financial management, using transport etc. [24, 31,
35, 38, 40, 47]. In addition to predicting [38], and being associated with [24, 47] declines in
ADLs, one study reported 67% of those with a HAND diagnosis to be considered functionally
impaired [31] and those with HAND were significantly more likely to be classed as ‘dependent’
[40, 47]. Experientially, participants described how difficulties with ADLs affected their QoL as
it lessened their ability to be independent.
Social relationships. Social QoL was examined in two studies [27, 30] as part of a broad
QoL measure, with both reporting social QoL to be significantly lower in PLWH with HAND.
No other studies examined this QoL domain quantitatively. Qualitatively, participants
described difficulties forming and maintaining friendships due to their cognitive impairment,
which in turn, impacted their self-esteem [49].
Environment. The impact of HAND on environmental QoL in PLWH was not examined
quantitively by any study, but was touched upon by participants in the qualitative study [49].
Participants recalled how stressful life events appeared to worsen their cognitive symptoms
and some felt their cognitive difficulties put them at risk in certain situations and impacted
their ability to work.
Spirituality/Religion/Personal beliefs. We found no reports pertaining to QoL in rela-
tion to spirituality, religion or personal beliefs.
Discussion
In chronic conditions ‘adding life to years’ is as essential as ‘adding years to life’ [55]. QoL has
increasingly been recognised as a valuable patient-reported outcome which is now more rou-
tinely measured in HIV clinical care and within memory services. QoL research in these popu-
lations dictates the importance of specificity when applying QoL measurement [56, 57]:
evidence from PLWH and from those with cognitive impairment finds unique dimensions
influence QoL in these populations [22, 58–60]. Failure to capture and assess the relevant
domains of QoL results in interventions which may lack meaning to patients along with poten-
tially helpful interventions being undervalued, or the potential deleterious impacts of interven-
tions being missed. This review provides an important first step in understanding how QoL is
impacted for those PLWH with HAND by synthesizing what is currently known and identify-
ing what is currently missing.
It is striking that across the literature we found only two studies focused on QoL exclusively
as their main research outcome [27, 30]. These two studies found that QoL, as evaluated by the
MOS-HIV, was significant worse for PLWH with HAND than PLWH without HAND, both
overall and across a variety of QoL domains (all p< 0.04). An important consideration with
regard to these findings is that these studies were conducted during the very early stages of
effective ARV availability, with both studies reporting average time on effective ART as below
30 months. Therefore, while it can confidently be asserted that HAND impacts QoL, this find-
ing is possibly relatively time specific, and must be applied with caution to today’s patients–
who, in the vast majority of cases have been on effective ARV therapy for decades, of which
the cumulative impact of considerably better health and the downstream impact on QoL, must
be considerable.
Another finding across the majority of studies, is the impact HAND appears to have on psy-
chological QoL. The quantitative findings regarding psychological QoL appear to suggest there
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is a significant impact of HAND on psychological QoL: three studies [27, 30, 43] employing
standardised QoL instruments found a significant negative impact of HAND in PLWH vs.
PLWH without HAND [27, 30] and HIV- controls [43]. However, it must be noted that the
only recent study [43] (conducted in 2017 vs. 2003/4 [27, 30]), which examined this using a
standardised QoL instrument found a difference between groups when HAND was catego-
rised using the Multivariate Normative Method [61], and not when using Frascati Criteria
diagnostics. The authors note that this may be explained by the considerably mild and asymp-
tomatic participant sample used in the study, and thus finding should be generalised carefully
[43]. Mental health measures conducted by studies overall found higher instances of depressive
and anxious symptoms in those with HAND compared to controls [35, 40, 43, 50]. Given the
robust and well evidenced relationship between psychiatric symptoms and QoL [62] this pro-
vides more tentative evidence for an important effect of HAND on psychological QoL. This is
an important area for future research: it is well documented that PLWH report significantly
higher levels of depression than HIV-negative controls [63], any additive impact of HAND on
psychological QoL is important to understand so that psychological interventions in those
with HAND can address the psychological factors most relevant to improving psychological
QoL in this group.
A further key finding was the overwhelming focus on functional assessment seen in the stud-
ies included. All but one study [43] (the authors note the nature of HAND in their study was
very mild, which likely effected ability to detect group differences in outcomes) found signifi-
cant differences in functional ability and its impact on independent living. Areas of functioning
examined by studies included instrumental ADL (Lawson & Brody IADL Scale [31, 54] or Law-
son & Brody IADL Scale-modified [31, 54]), broad physical functioning ability and level of
independence (Karnofsky Performance Scale [29]) and self-reported functional abilities with
regard to memory, language and communication, dexterity, sensory-perceptual, and higher-
level cognitive abilities (POAFI [26]). Studies show functional disability has been demonstrated
consistently both within and across measures reflecting a wide array of functional skills, strongly
suggesting functional deficits impacting ability to live independently are seen commonly in
PLWH with HAND. Importantly, however, the functional impairments seen in those with
HAND appear to be relatively mild, with impacts primarily seen on complex ADLs. Indeed,
most studies did not provide contextual information pertaining the functional meaning of
scores, however relatively few participants were reported to have diagnosis of HAD which is
diagnosed based on severe functional impairments. Future research is needed to understand the
impact poor functioning and lessening independence has on QoL broadly. This is particularly
important given the relatedly mild form of HAND now most commonly seen, and given the
push to enhance person-centred HIV care, which demands a holistic understanding of difficul-
ties so that overall health is assessed along with the social, psychological, and environmental
aspects of HIV and poor cognition that can lead to negative outcomes [64].
Significantly, there is the considerable lack of research in this field. Other than the impact
of HAND on psychological QoL, functional ability, and impact on level of independence no
other domains of QoL have been investigated in any depth, if at all. Of note, is the lack of
research into the social effects of living with HAND. Indeed, there is a the wealth of literature
describing increased levels of loneliness in PLWH (particularly older PLWH) [65] and in those
with cognitive difficulties [66], and the downstream impact this has broad domains of QoL.
The importance of social connectedness for good QoL is evidenced to be pivotal in other clini-
cal populations [67, 68] and interventions addressing social factors such as loneliness have
shown good efficacy in PLWH. It would certainly be of value to better understand the mecha-
nisms which may be driving the poorer reported social QoL reported in this group [27, 30], so
that interventions which build this skill and provide social support can be developed. Similarly,
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very little information was found on how one’s environment impacts QoL and no studies
reported on the spiritual, religious, or existential dimensions of QOL purported to be impor-
tant to overall QoL by the WHO [69]. More research is needed to identify what may serve as
protective or mitigating factors on QoL, as this will be important to understand if we are seek-
ing to improve it. It is also of interest that no studies have examined the intersectional impact,
of having both HIV and HAND, two potentially stigmatised and long-term health conditions,
on QoL and their joint effects on health and wellbeing. Qualitative research is particularly valu-
able here, and while the qualitative study included in this review [49] has shone light on some
of these issues (e.g. participants reported struggling to maintain and form new friendships,
how instances of enacted stigma have impacted their confidence), more qualitative studies
looking at QoL directly would certainly be a beneficial first step in explicating the meaningful
constituents of QoL, the relationships between different variables, and the protective factors
on QoL in this group of patients.
The studies reviewed in this scoping review were predominately conducted in the USA,
however studies from a range of other countries were seen. Notably, no studies were con-
ducted in Africa, where the burden of HIV is highest, and samples were heavily weighted
toward male participants, despite no there being on gender disparity in PLWH with HAND.
Ethnicity of participants with HAND was infrequently reported, particularly in studies where
examination of HAND was not a primary aim. The impact of demographic variables on QoL
in this population is an important area of research missing from this field: in HIV clinical care,
demographic variables provide important clues to guide intervention development and imple-
mentation. Interestingly, a recent meta-analysis examined the sociodemographic impacts on
QoL in PLWH: finding low socioeconomic status, stigma, less education, and younger age to
negatively influence QoL, and increased social support to positively influence QoL [70]. This
study emphasises the importance of understanding sociodemographic influences on QoL in
PLWH with HAND particularly given the intersectional and compounding issues facing these
individuals. Studies were relatively evenly distributed across the time period, suggesting there
has not been increased interest in the area in recent times, this is in contrast to the increasing
attention QoL has been receiving in other chronic conditions, including HIV broadly [71].
One qualitative study met our inclusion criteria, all other studies examined QoL and/or
domains of QoL quantitatively. Most studies did not explore QoL in PLWH with HAND as a
primary aim, with comparisons between groups on QoL measures often part of a broad battery
of outcome variables assessed with relative brevity. The majority of studies used established
and generic instruments when examining QoL and its associated dimensions. Studies which
assessed QoL broadly, used either the MOS-HIV [52], the SF-36 [39] or the EEVGGP [46].
The MOS-HIV and SF-36 can be compared with relative consistency, as both measures are
based on the same concept and theoretical perspective of QoL [72]. However, neither of the
two studies [38, 43] which used the SF-36, report sub-domain scores and only one study [43]
reports MHS and PHS scores, making detailed conclusions challenging. Furthermore, unlike
the MOS-HIV, the SF-36 does not assess cognitive functioning, which is likely an important
area to assess this group of patients. We included studies which measured dimensions of QoL–
most examined were function and psychological state. The use of measures for both dimen-
sions was fairly homogenous: with the majority of studies employing either Lawson & Brody
IADL Scale [54] or Lawson & Brody IADL Scale -Modified [31], Karnofsky Performance Sta-
tus and Patient’s Own Assessment of Function Inventory [29], as measures of function (albeit
domains of functioning varied greatly across measures (see Table 3), and the Beck Depression
Inventory-II [34] and the Patient’s Health Questionnaire-9 [44], as measures of psychological
state. Given the homogeneity across studies with regard to comparison groups used (i.e. HIV-
and/or PLWH with HAND) comparisons between studies can broadly be drawn.
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The main strength of this research is that it is the first review exploring and synthesising
what is known about the impact of HAND on QoL in PLWH: taken cumulatively the findings
appear to indicate a significant impact on QoL–which needs to be considered both with regard
to patient clinical care and increased research attention. A second strength of this scoping
review is the systematic way in which it was performed. The search was conducted with com-
prehensive search terms, which identified a large number of studies across four leading data-
bases. Although the search was not exhaustive, the selected databases and the searches
performed were advised by experienced academic librarians in order to generate the widest
possible search for texts related to the population, concept, and context. Furthermore, we
applied stringent eligibility criteria to the assessment of cognitive impairment in studies
included, ensuring that the research ‘gold-standard’ Frascati criteria [6] was used to assess
HAND. Limitations of this review include the paucity of studies from sub-Saharan Africa,
where the burden of HIV is highest, along with a lack of examination of the sociodemographic
factors impacting QoL in this population. Furthermore, important consideration must be paid
to the context in which this research appears, whereby screening and diagnosing HIV-associ-
ated neurocognitive impairments remains relatively limited in clinical settings [2, 73], with no
consensus on screening tools and concerns regarding the importance of routine testing [74,
75], given the majority of instances are asymptomatic and services extremely limited [76].
Conclusions
QoL in PLWH with HAND is a significantly under reported field in HIV clinical care. Few
studies have examined QoL in this group of patients and in those that have the impact on func-
tion and subsequent level of independence of PLWH with HAND on QoL have been reported
most frequently. Studies appear to suggest PLWH with HAND do report lower QoL overall,
however more research is needed to confidently assert this. PLWH with HAND appear to
experience greater levels of functional impairments, albeit mildly, which likely impact their
QoL to varying extents. Psychological QoL appears to be lower in those with HAND, however
whether this manifests into clinical illness is undetermined. This may represent an important
target for interventions as improvements to mental health is likely lead to improved cognition,
and improved QoL. More research is needed to understand the degree to which QoL is
impacted by HAND, the dimensions of QoL which may be effected, and whether standard
conceptualisations (or, indeed, HIV or dementia specific models) of QoL capture QoL experi-
ences for this group, so that variables of interest can be identified and meaningful interven-
tions developed to improve QoL in this population. QoL outcomes have received increased
focus over the last two decades, and recent calls to include QoL in The WHO’s HIV/AIDS 90-
90-90 target is justified based on multiple sources of evidence finding significant impacts of liv-
ing with HIV on QoL [77–79]. While there is more need for research exploring QoL in those
living with HAND, the emerging evidence detailed in this review along with evidence from
those studies reporting poorer QoL in PLWH broadly, shows that a paradigm shift is required
when thinking about those living with HIV. Clinical care needs to reflect the realities of
patients’ lives and multidimensional support is required to ensure treatment effects are maxi-
mized and reflective of factors most important to patients.
Supporting information
S1 Table. Preferred reporting items for systematic reviews and meta-analyses extension
for Scoping Reviews (PRISMA-ScR) checklist.
(DOCX)
PLOS ONE Quality of life in people with HAND
PLOS ONE | https://doi.org/10.1371/journal.pone.0251944 May 19, 2021 18 / 23
Acknowledgments
We thank the staff at Brighton and Sussex Medical School Library for assistance with the sys-
tematic search.
Author Contributions
Conceptualization: Kate Alford, Stephanie Daley, Sube Banerjee, Jaime H. Vera.
Data curation: Kate Alford, Jaime H. Vera.
Formal analysis: Kate Alford, Jaime H. Vera.
Investigation: Kate Alford, Jaime H. Vera.
Methodology: Kate Alford, Stephanie Daley, Jaime H. Vera.
Project administration: Kate Alford.
Supervision: Stephanie Daley, Sube Banerjee, Jaime H. Vera.
Writing – original draft: Kate Alford.
Writing – review & editing: Kate Alford, Stephanie Daley, Sube Banerjee, Jaime H. Vera.
References
1. HIV.gov. Overview: Data & Trends: Global Statistics https://www.hiv.gov/hiv-basics/overview/data-and-
trends/global-statistics2020 [
2. Alford K, Banerjee S, Nixon E, O’Brien C, Pounds O, Butler A, et al. Assessment and Management of
HIV-Associated Cognitive Impairment: Experience from a Multidisciplinary Memory Service for People
Living with HIV. Brain Sci. 2019; 9(2). https://doi.org/10.3390/brainsci9020037 PMID: 30744034
3. Morgan EE, Woods SP, Rooney A, Perry W, Grant I, Letendre SL, et al. Intra-individual variability
across neurocognitive domains in chronic hepatitis C infection: elevated dispersion is associated with
serostatus and unemployment risk. Clin Neuropsychol. 2012; 26(4):654–74. https://doi.org/10.1080/
13854046.2012.680912 PMID: 22533778
4. Woods SP, Weber E, Weisz BM, Twamley EW, Grant I, Group HNRP. Prospective memory deficits are
associated with unemployment in persons living with HIV infection. Rehabil Psychol. 2011; 56(1):77–
84. https://doi.org/10.1037/a0022753 PMID: 21401289
5. Gorman AA, Foley JM, Ettenhofer ML, Hinkin CH, van Gorp WG. Functional consequences of HIV-
associated neuropsychological impairment. Neuropsychology review. 2009; 19(2):186–203. https://doi.
org/10.1007/s11065-009-9095-0 PMID: 19472057
6. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, et al. Updated research nosology for
HIV-associated neurocognitive disorders. Neurology. 2007; 69(18):1789–99. https://doi.org/10.1212/
01.WNL.0000287431.88658.8b PMID: 17914061
7. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5 ed. Wash-
ington, DC2013.
8. Heaton RK, Clifford DB, Franklin DR, Woods SP, Ake C, Vaida F, et al. HIV-associated neurocognitive
disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology. 2010; 75
(23):2087–96. https://doi.org/10.1212/WNL.0b013e318200d727 PMID: 21135382
9. De Francesco D, Underwood J, Post FA, Vera JH, Williams I, Boffito M, et al. Defining cognitive
impairment in people-living-with-HIV: the POPPY study. BMC Infect Dis. 2016; 16(1):617. https://doi.
org/10.1186/s12879-016-1970-8 PMID: 27793128
10. Till JE, Osoba D, Pater JL, Young JR. Research on health-related quality of life: dissemination into prac-
tical applications. Qual Life Res. 1994; 3(4):279–83. https://doi.org/10.1007/BF00434902 PMID:
7812281
11. Hass BK. A multidisciplinary concept analysis of quality of life. Western Journal of Nursing Research.
1999; 21(6):728–42. https://doi.org/10.1177/01939459922044153 PMID: 11512210
12. The World Health Organisation. WHOQOL: Measuring Quality of Life. Geneva; 2015.
PLOS ONE Quality of life in people with HAND
PLOS ONE | https://doi.org/10.1371/journal.pone.0251944 May 19, 2021 19 / 23
13. Lazarus JV, Safreed-Harmon K, Barton SE, Costagliola D, Dedes N, Del Amo Valero J, et al. Beyond
viral suppression of HIV—the new quality of life frontier. BMC Med. 2016; 14(1):94. https://doi.org/10.
1186/s12916-016-0640-4 PMID: 27334606
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